Supernus [SUPN] vs Alkermes plc [ALKS] Detailed Stock Comparison
Supernus
NASDAQ
Loading...
Alkermes plc
NASDAQ
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Supernus wins in 5 metrics, Alkermes plc wins in 14 metrics, with 0 ties. Alkermes plc appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Supernus | Alkermes plc | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 39.03 | 14.37 | Alkermes plc |
| Price-to-Book Ratio | 2.37 | 3.02 | Supernus |
| Debt-to-Equity Ratio | 2.99 | 4.47 | Supernus |
| PEG Ratio | 3.51 | -7.76 | Alkermes plc |
| EV/EBITDA | 15.32 | 9.84 | Alkermes plc |
| Profit Margin (TTM) | 9.70% | 23.15% | Alkermes plc |
| Operating Margin (TTM) | 6.73% | 23.80% | Alkermes plc |
| EBITDA Margin (TTM) | 6.73% | 23.80% | Alkermes plc |
| Return on Equity | 6.38% | 23.94% | Alkermes plc |
| Return on Assets (TTM) | 2.39% | 10.49% | Alkermes plc |
| Free Cash Flow (TTM) | $171.23M | $405.64M | Alkermes plc |
| 1-Year Return | 28.34% | 6.44% | Supernus |
| Price-to-Sales Ratio (TTM) | 3.78 | 3.26 | Alkermes plc |
| Enterprise Value | $2.03B | $3.97B | Alkermes plc |
| EV/Revenue Ratio | 3.05 | 2.64 | Alkermes plc |
| Gross Profit Margin (TTM) | 89.83% | 87.34% | Supernus |
| Revenue per Share (TTM) | $12 | $9 | Supernus |
| Earnings per Share (Diluted) | $1.15 | $2.07 | Alkermes plc |
| Beta (Stock Volatility) | 0.74 | 0.43 | Alkermes plc |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Supernus vs Alkermes plc Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Supernus | 3.60% | 5.13% | 37.37% | 40.07% | 37.33% | 23.20% |
| Alkermes plc | 2.37% | 2.41% | 10.06% | -1.00% | -16.24% | 3.48% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Supernus | 28.34% | 32.62% | 102.80% | 152.13% | 651.76% | 651.76% |
| Alkermes plc | 6.44% | 21.23% | 81.96% | -52.89% | 116.99% | 72.16% |
Performance & Financial Health Analysis: Supernus vs Alkermes plc
| Metric | SUPN | ALKS |
|---|---|---|
| Market Information | ||
| Market Cap | $2.52B | $4.91B |
| Market Cap Category | Mid cap | Mid cap |
| 10 Day Avg. Volume | 854,070 | 1,312,350 |
| 90 Day Avg. Volume | 969,440 | 1,873,647 |
| Last Close | $44.88 | $29.75 |
| 52 Week Range | $29.16 - $45.01 | $25.56 - $36.45 |
| % from 52W High | -0.29% | -18.38% |
| All-Time High | $61.25 (Jun 25, 2018) | $98.50 (Feb 28, 2000) |
| % from All-Time High | -26.73% | -69.80% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | -0.02% |
| Quarterly Earnings Growth | 0.13% | -0.05% |
| Financial Health | ||
| Profit Margin (TTM) | 0.10% | 0.23% |
| Operating Margin (TTM) | 0.07% | 0.24% |
| Return on Equity (TTM) | 0.06% | 0.24% |
| Debt to Equity (MRQ) | 2.99 | 4.47 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $18.96 | $9.84 |
| Cash per Share (MRQ) | $9.32 | $6.15 |
| Operating Cash Flow (TTM) | $187.06M | $521.00M |
| Levered Free Cash Flow (TTM) | $150.12M | $345.67M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Supernus vs Alkermes plc
| Metric | SUPN | ALKS |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 39.03 | 14.37 |
| Forward P/E | 23.75 | 14.80 |
| PEG Ratio | 3.51 | -7.76 |
| Price to Sales (TTM) | 3.78 | 3.26 |
| Price to Book (MRQ) | 2.37 | 3.02 |
| Market Capitalization | ||
| Market Capitalization | $2.52B | $4.91B |
| Enterprise Value | $2.03B | $3.97B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.05 | 2.64 |
| Enterprise to EBITDA | 15.32 | 9.84 |
| Risk & Other Metrics | ||
| Beta | 0.74 | 0.43 |
| Book Value per Share (MRQ) | $18.96 | $9.84 |
Financial Statements Comparison: Supernus vs Alkermes plc
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SUPN | ALKS |
|---|---|---|
| Revenue/Sales | $149.82M | $306.51M |
| Cost of Goods Sold | $15.76M | $49.20M |
| Gross Profit | $134.06M | $257.31M |
| Research & Development | $26.93M | $71.82M |
| Operating Income (EBIT) | $-2.60M | $13.79M |
| EBITDA | $25.45M | $32.91M |
| Pre-Tax Income | $-5.83M | $25.49M |
| Income Tax | $6.00M | $3.03M |
| Net Income (Profit) | $-11.83M | $22.46M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SUPN | ALKS |
|---|---|---|
| Cash & Equivalents | $115.85M | $399.81M |
| Total Current Assets | $687.58M | $1.48B |
| Total Current Liabilities | $281.77M | $443.73M |
| Long-Term Debt | $26.37M | $67.81M |
| Total Shareholders Equity | $1.03B | $1.51B |
| Retained Earnings | $544.60M | $-953.99M |
| Property, Plant & Equipment | $0 | $82.41M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SUPN | ALKS |
|---|---|---|
| Operating Cash Flow | $22.33M | $122.31M |
| Capital Expenditures | $-327,000 | $-8.40M |
| Free Cash Flow | $30.27M | $88.70M |
| Debt Repayment | N/A | $0 |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | SUPN | ALKS |
|---|---|---|
| Shares Short | 5.08M | 13.82M |
| Short Ratio | 6.80 | 6.35 |
| Short % of Float | 0.13% | 0.12% |
| Average Daily Volume (10 Day) | 854,070 | 1,312,350 |
| Average Daily Volume (90 Day) | 969,440 | 1,873,647 |
| Shares Outstanding | 55.74M | 162.18M |
| Float Shares | 48.90M | 162.42M |
| % Held by Insiders | 0.04% | 0.01% |
| % Held by Institutions | 1.09% | 1.05% |
Dividend Analysis & Yield Comparison: Supernus vs Alkermes plc
| Metric | SUPN | ALKS |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |